APPLICATIONS PUBLISHED 20 AUGUST 2003
Published: 1-Feb-2004
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Production of microspheres
Epic Therapeutics 1335661*
Implant dosage form and use thereof for the delivery of a cholesterol lowering agent
Durect 1335704*
Preparation of drug particles using evaporation precipitation into aqueous solutions
Board of Regents, The University of Texas System 1335705*
Microspheres of pancreatic enzymes with high stability
Eurand International 1335706*
Novel formulations of carvedilol
SmithKline Beecham Corp 1335707*
Controlled release metformin compsns
Andrx 1335708*
Capsule of cellulose derivatives such as HPMC containing bezimidazole derivatives such as omeprazole
LEK farmacevtska druzba 1335709*
Soft capsules comprising a starch mixture having a reduced branching degree
Celanese Ventyres 1335710*
Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closures
Alza Corp 1335711*
Multilayered supporting construction for plaster systems containing an active ingredient
Beiersdorf 1335712*
Flexible barrier film for a support material for medical applications
Beiersdorf 1335713*
Skin friendly active ingredient plaster for especially transdermal administration of etheric oils
Beiersdorf 1335714*
Skin friendly active ingredient plaster for transdermal administration of rubrefacient active substances
Beiersdorf 1335715*
Novel use of 5-HT 1A agonists and selective serotonin reuptake inhibitors
Merck Patent 1335716*
Treatment of PCP addiction and PCP addiction-related behaviour
Brookhaven Science Associates 1335717*
6-methyl-2-naphthylacetic acid prodrugs
Nobex Corp 1335718*
Treating eczema and/or psoriasis
Meracol Corp 1335719*
Sulphonamides for the treatment of central nervous system diseases
Bayer 1335720*
Method of treating and preventing migraine headaches
Pharmacia & Upjohn 1335721*
Compounds useful in treatment of CNS disorders
SmithKline Beecham 1335722*
Use of stimulators of soluble guanylate cyclase for treating osteoporosis
Bayer 1335723*
Novel use of certain insulin sensitisers or PPAR-gamma agonists
SmithKline Beecham 1335724*
Use of CCI-779 as an antineoplastic agent
Wyeth 1335725*
Modified prodrugs forms of AP/AMP
Vion Pharmaceuticals 1335726*
Method for inhibiting cataracts
Eli Lilly 1335727*
Novel medicament compsns based on tiotropium salts and on salmeterol salts
Boehringer Ingelheim Pharma 1335728*
Inhalation solution formulation containing a tiotropium salt
Boehringer Ingelheim Pharma 1335729*
Treatment of premature ejaculation
Pfizer 1335730*
Antidiabetic compsns containing a biguanide and a sulphonamide
Merck Patent 1335731*
Food item for increasing cognitive capacity
Giventis 1335732*
Treatment of osteoporosis
Arthropharm 1335733*
Method for treating HIV
Bass, Ralph 1335734*
Vascularised tissue graft
Bernard O'Brien Institute of Microsurgery 1335735*
Compsns and methods for diagnosis and treatment of cardiovascular disorders
Athermastat 1335736*
Method for optimally delivering virus to a solid tumour mass
Oncolytics Biotech 1335737*
Method of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants
Proteotech 1335738*
Herbal compsn for treatment of neuronal injuries and neuronal degeneration, methods to prepare the same and uses thereof
Xia, Yong Chao 1335739*
Method and preparations having effect against allergic symptoms
Denovastella 1335740*
Methods of treatment or prevention of autoimmune diseases with CPG-containing polynucleotide
Yeda Research and Development 1335741*
Atherosclerosis vaccine
Forskapatent 1335742*
Inhibition or reversal of skin aging by actin-sequestering peptides
Regenerx Biopharmaceuticals 1335743*
SDF-1 beta expressing tumour cells and tumour vaccines
Genetics Institute 1335744*
Use of a compound antagonist of the ESM-1 protein for producing a medicine for treating cancer
Institut Pasteur De Lille 1335745*
Recombined anti-GPIIB/IIIA antibodies used for inhibiting angiogenesis
Asat AG Applied Science and Technology 1335746*
A compsn of sodium channel blocking compound
Nanning Maple Leaf Pharmaceutical 1335747*
Antibiotic adducts with natural polysaccharide polymers in the form of aqueous solutions
Pharma Biotech 1335748*
